Authors
O'Connor, Peter JManning, Francis C
Gordon, Anthony T
Billett, Michael A
Cooper, Donald P
Elder, Rhoderick H
Margison, Geoffrey P
Affiliation
Paterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, United Kingdom.Issue Date
2000
Metadata
Show full item recordAbstract
DNA damage is a critical factor in the initiation of chemically induced toxicities (including cancer), and the repair of this damage represents the cell's first line of defense against the deleterious effects of these agents. The various mechanisms of DNA repair are reviewed briefly and the actions of the DNA repair protein O6-alkylguanine DNA alkyltransferase (ATase) are used to illustrate how DNA repair can protect cells against alkylating agent-induced toxicities, mutagenesis, clastogenesis, and carcinogenesis. The effectiveness of this repair protein can be measured based on its ability to deplete levels of its promutagenic substrate O6-methylguanine (O6-meG) in the DNA of cells. These studies reveal that the repair of O6-meG from DNA occurs heterogeneously, both intra- and intercellularly. Even in cells that repair O6-meG hyperefficiently, certain regions of chromatin DNA are repaired with difficulty, and in other regions they are not repaired at all; most likely this lack of repair is a result of the location of the lesion in the DNA sequence. When individual cells are compared within a tissue, some cells are clearly repair deficient, because the O6-meG can persist in DNA for many weeks, whereas in other cells, it is removed within a matter of hours. The role of these repair-deficient cells as targets for alkylating agent induced carcinogenesis is considered. The mechanisms of the homeostatic control of DNA repair function in mammalian cells are not yet well understood. Because there are now indications of the mechanisms by which the level of DNA damage may be sensed (and so influence the activity of the ATase repair protein), this is an important area for future study.Citation
DNA repair: kinetics and thresholds., 28 (3):375-81 Toxicol PatholJournal
Toxicologic PathologyDOI
10.1177/019262330002800304PubMed ID
10862553Type
ArticleLanguage
enISSN
0192-6233ae974a485f413a2113503eed53cd6c53
10.1177/019262330002800304
Scopus Count
Collections
Related articles
- O6-Alkylguanine-DNA alkyltransferase: influence on susceptibility to the genetic effects of alkylating agents.
- Authors: Kyrtopoulos SA
- Issue date: 1998 Dec 28
- Protection of mammalian cells against chloroethylating agent toxicity by an O6-benzylguanine-resistant mutant of human O6-alkylguanine-DNA alkyltransferase.
- Authors: Hickson I, Fairbairn LJ, Chinnasamy N, Dexter TM, Margison GP, Rafferty JA
- Issue date: 1996 Oct
- The bacterial alkyltransferase-like (eATL) protein protects mammalian cells against methylating agent-induced toxicity.
- Authors: Tomaszowski KH, Aasland D, Margison GP, Williams E, Pinder SI, Modesti M, Fuchs RP, Kaina B
- Issue date: 2015 Apr
- Glial cell-specific differences in repair of O6-methylguanine.
- Authors: LeDoux SP, Williams BA, Hollensworth BS, Shen C, Thomale J, Rajewsky MF, Brent TP, Wilson GL
- Issue date: 1996 Dec 15
- Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
- Authors: Dosch J, Kaina B
- Issue date: 1996 Nov 7